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Epilepsy is a heterogeneous group of disorders. It is the
most common neurological disorder after the stroke, with
a 2–3% life-time risk of being given a diagnosis of epi-
lepsy [1]. Antiepileptogenic drugs that retard or prevent
epileptogenesis are not yet available [2]. Extract of the
plant Aquilegia vulgaris is widely used in folk medicine as
an antiepileptic medicament [3]. We have previously
demonstrated that oleamid – sleep inducing lipid and
myo-inositol are two compounds acting on γ-aminobutu-
ric acid type A receptors and hence candidates determin-
ing the anti-epileptic properties of the plant Aquilegia
vulgaris [4]. Further it was shown that myo-inositol
reduces the strength of seizures induced either by penty-
lentetrazol or kainic acid in rats. In the present work we
are demonstrating that oleamid also posseses anti-epilep-
tic features and significantly decreases the degrees of con-
vulsions induced by pentylentetrazole in rats.
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